Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience. (February 2017) - Besson, C.; Waissi, W.; Velten, M.; Nguyen Them, L.; Schott, R.; Prebay, D.; Etienne-Selloum, N.